Nonstereotyped Responding in Positive Schizotypy after a Single Dose of Levodopa

被引:0
|
作者
Christine Mohr
Theodor Landis
Peter S Sandor
Marc Fathi
Peter Brugger
机构
[1] Functional Brain Mapping Laboratory,
[2] University Hospital Geneva,undefined
[3] Neurology Clinic,undefined
[4] University Hospital Geneva,undefined
[5] Clinical Chemistry Central Laboratory,undefined
[6] University Hospital Geneva,undefined
[7] Rehabilitation Clinic,undefined
[8] University Hospital Geneva,undefined
[9] Neurology Clinic,undefined
[10] University Hospital Zurich,undefined
来源
Neuropsychopharmacology | 2004年 / 29卷
关键词
dopamine; turning behavior; stereotypy; perseveration; positive symptoms;
D O I
暂无
中图分类号
学科分类号
摘要
Stereotyped behavior and left-sided orientation biases, associated with the dopamine (DA) system, were observed in populations of the schizophrenia spectrum disorders. We investigated whether heightened DA concentrations influence both side biases and stereotyped responding in a visuo-motor computer task, in which 90, 180, and 270° rotated objects had to be brought into a target position. To account for the role of the schizophrenia spectrum, task performance was also analyzed as a function of healthy participants' high or low magical ideation (MI), a positive schizotypal feature. The first 36 participants (20 women) remained substance free. In a second sample, 20 men received levodopa and 20 men a placebo in a double-blind procedure. Results showed that high MI scorers responded more stereotyped than low MI scorers, without being specifically biased towards the left side. Rotation preferences toward one or the other side made high MI scorers less flexible for objects efficiently to be rotated into the opposite direction. This inflexibility may reflect impaired left hemisphere functioning. Unexpectedly, in the levodopa group, high MI scorers performed superior to low MI scorers. Since DA actions appear to follow an inverted U-shape function, the ‘low’ performing high MI scorers profited from the enhanced DA availability. Our observation in the levodopa group points to a dissociation between schizotypy and schizophrenia: while cognitive improvement in schizophrenia can occur after treatment with atypical neuroleptic agents, in our positive schizotypal participants a DA agonist resulted in improved task performance. This dissociation may point to protective neurochemical mechanisms preventing healthy schizotypes from developing full-blown psychotic symptoms.
引用
收藏
页码:1741 / 1751
页数:10
相关论文
共 50 条
  • [21] Levodopa Induced Orthostatic Hypotension in Parkinson's Disease: A Single-Dose Response Study
    Thiankhaw, K.
    Tanprawate, S.
    Soontornpun, A.
    Nudsasarn, A.
    Chankrachang, S.
    MOVEMENT DISORDERS, 2018, 33 : S175 - S176
  • [22] Pharmacokinetic comparison of Sinemet® and Grifoparkin® (levodopa/carbidopa) in Parkinson's disease:: a single dose study
    Chaná, P
    Fierro, A
    Reyes-Parada, M
    Sáez-Briones, P
    REVISTA MEDICA DE CHILE, 2003, 131 (06) : 623 - 631
  • [23] Levodopa induced orthostatic hypotension in Parkinson's disease: A single-dose response study
    Thiankhaw, K.
    Tanprawate, S.
    Soontornpun, A.
    Nudsasarn, A.
    Chankrachang, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 1039 - 1039
  • [24] Concomitant medication use and Levodopa equivalent daily dose requirements after Foslevodopa/foscarbidopa initiation
    Santos Garcia, D.
    Bergmann, L.
    Bergmans, B.
    Bergquist, F.
    Criswell, S.
    Fung, V.
    Jia, J.
    Kukreja, P.
    Pavasia, N.
    Robieson, W.
    Zhang, Z.
    Standaert, D.
    MOVEMENT DISORDERS, 2022, 37 : S349 - S350
  • [25] Thrombocytopenia after a single test dose of methotrexate
    Jih, DM
    Werth, VP
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 39 (02) : 349 - 351
  • [27] STEROID DYNAMICS AFTER A SINGLE DOSE OF METYRAPONE
    ZACHMANN, M
    VOLLMIN, JA
    ZAGALAK, M
    ACTA ENDOCRINOLOGICA, 1973, : 89 - 89
  • [28] Acute catatonia after a single dose of ecstasy
    Masi, G
    Mucci, M
    Floriani, C
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2002, 41 (08): : 892 - 892
  • [29] PHARMACOKINETICS OF NOMIFENSINE AFTER A SINGLE ORAL DOSE
    MCINTYRE, IM
    NORMAN, TR
    BURROWS, GD
    MAGUIRE, KP
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (05) : 740 - 743
  • [30] LOPERAMIDE TOXICITY IN A CHILD AFTER A SINGLE DOSE
    MINTON, NA
    SMITH, PGD
    BRITISH MEDICAL JOURNAL, 1987, 294 (6584): : 1383 - 1383